11-5225727-C-A
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000518.5(HBB):c.316-1G>T variant causes a splice acceptor, intron change. The variant allele was found at a frequency of 0.00000137 in 1,461,790 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000518.5 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HBB | ENST00000335295.4 | c.316-1G>T | splice_acceptor_variant, intron_variant | Intron 2 of 2 | 1 | NM_000518.5 | ENSP00000333994.3 | |||
HBB | ENST00000647020.1 | c.316-1G>T | splice_acceptor_variant, intron_variant | Intron 2 of 2 | ENSP00000494175.1 | |||||
HBB | ENST00000475226.1 | n.248-1G>T | splice_acceptor_variant, intron_variant | Intron 1 of 1 | 2 | |||||
HBB | ENST00000633227.1 | n.*132-1G>T | splice_acceptor_variant, intron_variant | Intron 2 of 2 | 3 | ENSP00000488004.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461790Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 727214
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
beta Thalassemia Pathogenic:2
- -
Variant summary: HBB c.316-1G>T is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. 5/5 computational tools predict that the variant significantly impacts normal splicing by abolishing a 3' acceptor site. However, these predictions have yet to be confirmed by functional studies. The variant was absent in 251150 control chromosomes (gnomAD). c.316-1G>T has been reported in the literature in individuals affected with Beta Thalassemia (Najmabadi_2002). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory has submitted a clinical-significance assessment for this variant to ClinVar (after 2014) and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
not provided Pathogenic:1
The HBB c.316-1G>T variant disrupts a canonical splice-acceptor site and is predicted to interfere with normal HBB mRNA splicing. This variant has been reported in the published literature in individuals affected with microcytic anemia or beta-thalassemia (PMID: 9101288 (1997), 12368169 (2002), 26290351 (2015), 33335418 (2020), and 38322302 (2024)). This variant has not been reported in large, multi-ethnic general populations (Genome Aggregation Database, http://gnomad.broadinstitute.org). Based on the available information, this variant is classified as likely pathogenic -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at